Normal view
-
Journal of Medical Internet Research
-
Evaluating Peer Online Forums to Support Health: Ethical and Practical Challenges
Many people use peer online forums to seek support for health-related problems. More research is needed to understand the impacts of forum use, and how these are generated. However, there are significant ethical and practical challenges with the methods available to do the required research. We examine the key challenges associated with conducting each of the most commonly used online data collection methods: surveys, interviews, forum post analysis; and triangulation of these methods. Based on
-
Journal of Medical Internet Research
- Correction: Uncovering Social States in Healthy and Clinical Populations Using Digital Phenotyping and Hidden Markov Models: Observational Study
-
npj Digital Medicine
-
Context matching is not reasoning when performing generalized clinical evaluation of generative language models
npj Digital Medicine, Published online: 27 December 2025; doi:10.1038/s41746-025-02253-2Context matching is not reasoning when performing generalized clinical evaluation of generative language models
Context matching is not reasoning when performing generalized clinical evaluation of generative language models
npj Digital Medicine, Published online: 27 December 2025; doi:10.1038/s41746-025-02253-2
Context matching is not reasoning when performing generalized clinical evaluation of generative language models-
npj Digital Medicine
-
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
npj Digital Medicine, Published online: 26 December 2025; doi:10.1038/s41746-025-02277-8A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains
npj Digital Medicine, Published online: 26 December 2025; doi:10.1038/s41746-025-02277-8
A novel evaluation benchmark for medical LLMs illuminating safety and effectiveness in clinical domains-
MRD
-
Comparison of liquid biopsy-based technologies for cancer screening
Crit Rev Clin Lab Sci. 2025 Dec 27:1-12. doi: 10.1080/10408363.2025.2606357. Online ahead of print.ABSTRACTCirculating plasma DNA has found important applications in diverse medical fields, including prenatal testing, transplantation, and especially cancer. Many companies have developed products for detecting minimal residual disease, selecting or monitoring therapy, assessing prognosis, and confirming diagnosis. One major application is in screening asymptomatic individuals for the presence of
Comparison of liquid biopsy-based technologies for cancer screening
Crit Rev Clin Lab Sci. 2025 Dec 27:1-12. doi: 10.1080/10408363.2025.2606357. Online ahead of print.
ABSTRACT
Circulating plasma DNA has found important applications in diverse medical fields, including prenatal testing, transplantation, and especially cancer. Many companies have developed products for detecting minimal residual disease, selecting or monitoring therapy, assessing prognosis, and confirming diagnosis. One major application is in screening asymptomatic individuals for the presence of cancer. Screening may facilitate better clinical outcomes through earlier interventions. Collectively, these technologies are widely known as "liquid biopsies". After the extraction of free DNA from the circulation, it is analyzed by various molecular techniques to explore differences between DNA originating from normal cells and cancer cells. Circulating plasma DNA originating from tumors (ctDNA) is expected to harbor the same molecular changes as tumor tissue itself. Thus, ctDNA is considered a surrogate of cancer tissue, but without the need to perform invasive biopsies to obtain it. Many new diagnostic companies have taken advantage of this new biomarker and developed technologies for screening for one or multiple cancers. We previously estimated the amount of ctDNA in circulation, which is admixed with DNA originating from normal cells. We concluded that since only a small fraction of the whole plasma (3 liters) is used for testing (3 to 4 mL), it is possible that the retrieved ctDNA may not be enough for cancer diagnosis in all patients. This problem is more acute with small tumors. Here, we mention some companies in the "liquid biopsy" arena and analyze their clinical data to establish if their tests are close to entering the clinic. We conclude from this analysis that current data do not support the use of these technologies for population screening due to many false negative and false positive results.
PMID:41454842 | DOI:10.1080/10408363.2025.2606357
-
MRD
-
Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025
J Liq Biopsy. 2025 Nov 29;10:100449. doi: 10.1016/j.jlb.2025.100449. eCollection 2025 Dec.ABSTRACTThe role of liquid biopsy in oncological care continues to expand, with multiple studies presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC 2025). This review summarizes recent advances in liquid biopsy for thoracic oncology, encompassing both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In early detecti
Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025
J Liq Biopsy. 2025 Nov 29;10:100449. doi: 10.1016/j.jlb.2025.100449. eCollection 2025 Dec.
ABSTRACT
The role of liquid biopsy in oncological care continues to expand, with multiple studies presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC 2025). This review summarizes recent advances in liquid biopsy for thoracic oncology, encompassing both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). In early detection and screening, proteomic profiling has identified potential biomarkers predictive of future lung cancer risk. The integration of proteomics with clinical and imaging data can improve pulmonary nodule malignancy prediction. In resectable NSCLC, tumour-informed whole-genome sequencing (WGS) assay demonstrated high sensitivity for minimal residual disease (MRD) detection, with MRD clearance following neoadjuvant osimertinib or chemo-immunotherapy associated with favorable outcomes. In advanced NSCLC, longitudinal liquid biopsy analyses reveal dynamic subclonal evolution driving early treatment resistance. Circulating tumor DNA (ctDNA) clearance following targeted therapy in MET exon 14 skipping and BRAF-mutated tumors was associated with improved clinical outcomes. Emerging biomarkers such as ctDNA tumour fraction and circulating microRNA signatures are promising for radiotherapy stratification and prediction of immunotherapy-related toxicities. In SCLC, MRD monitoring enables earlier detection of disease progression and supports ctDNA-guided selection of patients for consolidation immunotherapy following chemotherapy. Overall, these advances demonstrate the expanding role of liquid biopsy in improving early detection, guiding treatment, and improving disease monitoring in lung cancer.
PMID:41438843 | PMC:PMC12720026 | DOI:10.1016/j.jlb.2025.100449
-
TechCrunch
-
Investors share what to remember while raising a Series A
Investors share what founders should remember if looking to raise a Series A.
Investors share what to remember while raising a Series A
-
TechCrunch
-
The year data centers went from backend to center stage
Data centers are no longer the boring tech issue they once were.
The year data centers went from backend to center stage
-
MIT Technology Review
-
Take our quiz on the year in health and biotechnology
In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs have expanded in scope, and there have been some real “omg” biotech stories from the fields of gene therapy, IVF, neurotech, and more. As always, the team at MIT Technology Review has been putting together our 2026 list of breakthrough technologies. That will be published in the new year (watch this space)
Take our quiz on the year in health and biotechnology
In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs have expanded in scope, and there have been some real “omg” biotech stories from the fields of gene therapy, IVF, neurotech, and more.
As always, the team at MIT Technology Review has been putting together our 2026 list of breakthrough technologies. That will be published in the new year (watch this space). In the meantime, my colleague Antonio Regalado has compiled his traditional list of the year’s worst technologies.
I’m inviting you to put your own memory to the test. Just how closely have you been paying attention to the Checkup emails that have been landing in your inbox this year?!
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.
-
cs.AI, q-bio.NC updates on arXiv.org
-
The Principle of Proportional Duty: A Knowledge-Duty Framework for Ethical Equilibrium in Human and Artificial Systems
arXiv:2512.15740v1 Announce Type: new Abstract: Traditional ethical frameworks often struggle to model decision-making under uncertainty, treating it as a simple constraint on action. This paper introduces the Principle of Proportional Duty (PPD), a novel framework that models how ethical responsibility scales with an agent's epistemic state. The framework reveals that moral duty is not lost to uncertainty but transforms: as uncertainty increases, Action Duty (the duty to act decisively) is pro
The Principle of Proportional Duty: A Knowledge-Duty Framework for Ethical Equilibrium in Human and Artificial Systems
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI Needs Physics More Than Physics Needs AI
arXiv:2512.16344v1 Announce Type: new Abstract: Artificial intelligence (AI) is commonly depicted as transformative. Yet, after more than a decade of hype, its measurable impact remains modest outside a few high-profile scientific and commercial successes. The 2024 Nobel Prizes in Chemistry and Physics recognized AI's potential, but broader assessments indicate the impact to date is often more promotional than technical. We argue that while current AI may influence physics, physics has signific
AI Needs Physics More Than Physics Needs AI
-
npj Digital Medicine
-
Machine learning-based predictions of healthcare contacts following emergency hospitalisation using electronic health records
npj Digital Medicine, Published online: 17 December 2025; doi:10.1038/s41746-025-02138-4Machine learning-based predictions of healthcare contacts following emergency hospitalisation using electronic health records
Machine learning-based predictions of healthcare contacts following emergency hospitalisation using electronic health records
npj Digital Medicine, Published online: 17 December 2025; doi:10.1038/s41746-025-02138-4
Machine learning-based predictions of healthcare contacts following emergency hospitalisation using electronic health records-
cs.AI, q-bio.NC updates on arXiv.org
-
Distributional AGI Safety
arXiv:2512.16856v1 Announce Type: new Abstract: AI safety and alignment research has predominantly been focused on methods for safeguarding individual AI systems, resting on the assumption of an eventual emergence of a monolithic Artificial General Intelligence (AGI). The alternative AGI emergence hypothesis, where general capability levels are first manifested through coordination in groups of sub-AGI individual agents with complementary skills and affordances, has received far less attention.
Distributional AGI Safety
-
cs.AI, q-bio.NC updates on arXiv.org
-
Data-Chain Backdoor: Do You Trust Diffusion Models as Generative Data Supplier?
arXiv:2512.15769v1 Announce Type: cross Abstract: The increasing use of generative models such as diffusion models for synthetic data augmentation has greatly reduced the cost of data collection and labeling in downstream perception tasks. However, this new data source paradigm may introduce important security concerns. This work investigates backdoor propagation in such emerging generative data supply chains, namely Data-Chain Backdoor (DCB). Specifically, we find that open-source diffusion mo
Data-Chain Backdoor: Do You Trust Diffusion Models as Generative Data Supplier?
-
cs.AI, q-bio.NC updates on arXiv.org
-
AI4EOSC: a Federated Cloud Platform for Artificial Intelligence in Scientific Research
arXiv:2512.16455v1 Announce Type: cross Abstract: In this paper, we describe a federated compute platform dedicated to support Artificial Intelligence in scientific workloads. Putting the effort into reproducible deployments, it delivers consistent, transparent access to a federation of physically distributed e-Infrastructures. Through a comprehensive service catalogue, the platform is able to offer an integrated user experience covering the full Machine Learning lifecycle, including model deve
AI4EOSC: a Federated Cloud Platform for Artificial Intelligence in Scientific Research
-
cs.AI, q-bio.NC updates on arXiv.org
-
XTC, A Research Platform for Optimizing AI Workload Operators
arXiv:2512.16512v1 Announce Type: cross Abstract: Achieving high efficiency on AI operators demands precise control over computation and data movement. However, existing scheduling languages are locked into specific compiler ecosystems, preventing fair comparison, reuse, and evaluation across frameworks. No unified interface currently decouples scheduling specification from code generation and measurement. We introduce XTC, a platform that unifies scheduling and performance evaluation across co
XTC, A Research Platform for Optimizing AI Workload Operators
-
cs.AI, q-bio.NC updates on arXiv.org
-
Plausibility as Failure: How LLMs and Humans Co-Construct Epistemic Error
arXiv:2512.16750v1 Announce Type: cross Abstract: Large language models (LLMs) are increasingly used as epistemic partners in everyday reasoning, yet their errors remain predominantly analyzed through predictive metrics rather than through their interpretive effects on human judgment. This study examines how different forms of epistemic failure emerge, are masked, and are tolerated in human AI interaction, where failure is understood as a relational breakdown shaped by model-generated plausibil
Plausibility as Failure: How LLMs and Humans Co-Construct Epistemic Error
-
cs.AI, q-bio.NC updates on arXiv.org
-
Multi-Modality Collaborative Learning for Sentiment Analysis
arXiv:2501.12424v2 Announce Type: replace-cross Abstract: Multimodal sentiment analysis (MSA) identifies individuals' sentiment states in videos by integrating visual, audio, and text modalities. Despite progress in existing methods, the inherent modality heterogeneity limits the effective capture of interactive sentiment features across modalities. In this paper, by introducing a Multi-Modality Collaborative Learning (MMCL) framework, we facilitate cross-modal interactions and capture enhanced
Multi-Modality Collaborative Learning for Sentiment Analysis
-
cs.AI, q-bio.NC updates on arXiv.org
-
Towards Practical Alzheimer's Disease Diagnosis: A Lightweight and Interpretable Spiking Neural Model
arXiv:2506.09695v3 Announce Type: replace-cross Abstract: Early diagnosis of Alzheimer's Disease (AD), particularly at the mild cognitive impairment stage, is essential for timely intervention. However, this process faces significant barriers, including reliance on subjective assessments and the high cost of advanced imaging techniques. While deep learning offers automated solutions to improve diagnostic accuracy, its widespread adoption remains constrained due to high energy requirements and c
Towards Practical Alzheimer's Disease Diagnosis: A Lightweight and Interpretable Spiking Neural Model
-
cs.AI, q-bio.NC updates on arXiv.org
-
Constitutional Law and AI Governance: Constraints on Model Licensing and Research Classification
arXiv:2509.05361v2 Announce Type: replace-cross Abstract: Transformative AI systems may pose unprecedented catastrophic risks, but the U.S. Constitution places significant constraints on the government's ability to govern this technology. This paper examines how the First Amendment, administrative law, and the Fourteenth Amendment shape the legal vulnerability of two regulatory proposals: model licensing and AI research classification. While the First Amendment may provide some degree of protec